DYN
Price
$26.10
Change
+$0.12 (+0.46%)
Updated
Aug 21 closing price
Capitalization
4.87B
67 days until earnings call
Intraday BUY SELL Signals
VNDA
Price
$5.28
Change
-$0.10 (-1.86%)
Updated
Aug 21 closing price
Capitalization
319.24M
73 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DYN vs VNDA

DYN vs VNDA Comparison Chart in %
View a ticker or compare two or three
VS
DYN vs. VNDA commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Hold and VNDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (DYN: $26.10 vs. VNDA: $5.28)
Brand notoriety: DYN and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 42% vs. VNDA: 60%
Market capitalization -- DYN: $4.87B vs. VNDA: $319.24M
DYN [@Biotechnology] is valued at $4.87B. VNDA’s [@Biotechnology] market capitalization is $319.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 0 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • DYN’s FA Score: 0 green, 5 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, DYN is a better buy in the long-term than VNDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 2 TA indicator(s) are bullish while VNDA’s TA Score has 4 bullish TA indicator(s).

  • DYN’s TA Score: 2 bullish, 6 bearish.
  • VNDA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VNDA is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а +1.56% price change this week, while VNDA (@Biotechnology) price change was +1.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

DYN is expected to report earnings on Oct 29, 2026.

VNDA is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($4.87B) has a higher market cap than VNDA($319M). DYN YTD gains are higher at: 33.436 vs. VNDA (-40.136). VNDA has higher annual earnings (EBITDA): -147.75M vs. DYN (-502.36M). DYN has more cash in the bank: 898M vs. VNDA (202M). VNDA has less debt than DYN: VNDA (13.1M) vs DYN (219M). VNDA has higher revenues than DYN: VNDA (218M) vs DYN (0).
DYNVNDADYN / VNDA
Capitalization4.87B319M1,528%
EBITDA-502.36M-147.75M340%
Gain YTD33.436-40.136-83%
P/E RatioN/A126.00-
Revenue0218M-
Total Cash898M202M445%
Total Debt219M13.1M1,672%
FUNDAMENTALS RATINGS
DYN vs VNDA: Fundamental Ratings
DYN
VNDA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
95
Overvalued
PROFIT vs RISK RATING
1..100
88100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
3660
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DYN's Valuation (42) in the Electric Utilities industry is somewhat better than the same rating for VNDA (95) in the Biotechnology industry. This means that DYN’s stock grew somewhat faster than VNDA’s over the last 12 months.

DYN's Profit vs Risk Rating (88) in the Electric Utilities industry is in the same range as VNDA (100) in the Biotechnology industry. This means that DYN’s stock grew similarly to VNDA’s over the last 12 months.

DYN's SMR Rating (99) in the Electric Utilities industry is in the same range as VNDA (99) in the Biotechnology industry. This means that DYN’s stock grew similarly to VNDA’s over the last 12 months.

DYN's Price Growth Rating (36) in the Electric Utilities industry is in the same range as VNDA (60) in the Biotechnology industry. This means that DYN’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's P/E Growth Rating (3) in the Biotechnology industry is significantly better than the same rating for DYN (100) in the Electric Utilities industry. This means that VNDA’s stock grew significantly faster than DYN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DYNVNDA
RSI
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
66%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
Bullish Trend 6 days ago
68%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 3 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signal:
Gain/Loss:
VNDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIOVX18.450.21
+1.15%
Nuveen International Opps W
TWRCX46.300.33
+0.72%
American Century Growth C
KLGIX57.950.32
+0.56%
NYLI WMC Growth Class I
NEXTX38.080.18
+0.47%
Shelton Sustainable Equity Investor
NOIEX21.010.08
+0.38%
Northern Income Equity

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+0.46%
RNA - DYN
64%
Loosely correlated
-2.08%
IDYA - DYN
46%
Loosely correlated
+1.43%
BBIO - DYN
46%
Loosely correlated
-1.74%
VYGR - DYN
45%
Loosely correlated
+2.11%
KURA - DYN
45%
Loosely correlated
+1.54%
More